In a whirlwind transaction handled by Boston’s Palmer & Dodge, Antigenics — a company that develops treatments for cancers, infectious diseases, and degenerative and autoimmune disorders — closed a $60-million stock offering in January. Instead of toasting in 2002 with ...

McDermott, Will & Emery inked a different type of “deal” this month when it officially set up shop in Munich, Germany, becoming one of the first Boston law firms to boast a German office. The firm now has offices throughout ...